Jamila Kwarteng, MS, PhD
Assistant Professor of Community Health
Locations
- Institute for Health and Equity
Contact Information
Biography
Dr. Jamila Kwarteng is an Assistant Professor in the Division of Community Health in the Institute for Health & Equity and a fellow in the NHLBI Obesity Health Disparities Research PRIDE (OHD PRIDE) cohort 9. Her research interests focus on promoting equitable health outcomes in obesity and cancer prevention and control among historically marginalized communities through community-engaged strategies. Her interests stem from her graduate work in public health and women’s studies, and her involvement in community-based participatory research projects in cardiovascular health.
Dr. Kwarteng earned her PhD in Health Behavior and Health Education at the University of Michigan in Ann Arbor, MI. In 2015, she joined ϰϲͼ as a Postdoc in the Department of Medicine, and became an Instructor and Fellow in the Primary Care Research Fellowship in 2017. During this time, she began her research on facilitators and barriers of behavior change and weight loss among African American breast cancer survivors through her secondary data analyses of African American breast cancer survivors in a weight loss study; and piloted a study funded by an American Cancer Society Institutional grant to explore whether increasing social support and social networks decreases mortality risk and improves quality of life among African American female cancer survivors. In 2019, Dr. Kwarteng was appointed to Assistant Professor of Community Health.
Dr. Kwarteng’s current research is broadly concerned with community capacity-building projects that aim to improve cancer prevention and control among African Americans and Latinos. She collaborates with various stakeholders in academic medicine and community organizations including recreational centers, churches, and care coordination agencies to develop programs and workshops on cancer prevention and screening. This collaborative work is funded by the Office of Minority Health, Health and Human Services (6 CPIMP201215-02-02, role: Co-PI); Advancing Healthier Wisconsin (FP00020550, role: Co-PI); NCATS (3UL1TR001436-08S2; role: Key personnel); and NHLBI (R-22-0105, role: Site PI).
Dr. Kwarteng is a member of the ϰϲͼ Cancer Center, the Clinical and Translational Science Institute, and the Cardiovascular Center. She serves on the Community Engagement Advisory Council, Professional Enrichment Committee, and the Community and Cancer Science Network Collaborative Workgroup for Breast Cancer Disparities. She enjoys serving on dissertation committees for students in the PhD program in Public and Community Health and mentoring undergraduate summer students in Student Centered Pipeline to Advance Research in Cancer Careers (SPARCC) and Summer Cancer Health Disparities Internship Program (CHIP).
Research Areas of Interest
- Cancer Survivors
- Exercise
- Obesity, Abdominal
- Quality of Life
- Risk Factors
- Surveys and Questionnaires
- Waist Circumference
- Weight Loss
- Women's Health
Research Experience
- Cancer Survivors
- Cardiovascular Diseases
- Health Equity
- Minority Health
- Obesity, Abdominal
- Poverty
- Quality of Life
- Risk Factors
- Surveys and Questionnaires
- United States
- Waist Circumference
- Weight Loss
Methodologies and Techniques
- Breast Neoplasms
- Cancer Survivors
- Exercise
- Obesity, Abdominal
- Quality of Life
- Risk Factors
- Waist Circumference
- Weight Loss
Educational Expertise
- Community-Based Participatory Research
- Health Behavior
- Health Education
- Health Risk Behaviors
- Health Status Disparities
- Minority Health
- Program Evaluation
- Public Health
- Women's Health
Research Interests
Publications
-
(Bikomeye JC, Awoyinka I, Kwarteng JL, Beyer AM, Rine S, Beyer KMM.) Heart Lung Circ. 2024 May;33(5):576-604 PMID: 38184426 PMCID: PMC11144115 SCOPUS ID: 2-s2.0-85181809389 01/07/2024
-
(Kwarteng JL, White K, Nevels D, Brown S, Stolley MR.) J Relig Health. 2024 Apr;63(2):1523-1537 PMID: 38453721 SCOPUS ID: 2-s2.0-85186850594 03/08/2024
-
(Awoyinka I, Tovar M, Young S, Beyer K, Kwarteng J, Knight J, Stolley M.) Support Care Cancer. 2024 Feb 21;32(3):178 PMID: 38381216 SCOPUS ID: 2-s2.0-85185668818 02/21/2024
-
(Kwarteng E, Kwarteng J, Bansal N, Cebe M.) International Symposium on Medical Information and Communication Technology, ISMICT. 2024:22-27 SCOPUS ID: 2-s2.0-85210555898 01/01/2024
-
(Johnson JL, Coleman A, Kwarteng JL, Holmes AU, Kermah D, Bruce MA, Beech BM.) Int J Environ Res Public Health. 2023 May 24;20(11) PMID: 37297546 PMCID: PMC10253130 SCOPUS ID: 2-s2.0-85163065065 06/10/2023
-
(Kwarteng JL, Matthews L, Banerjee A, Sharp LK, Gerber BS, Stolley MR.) J Cancer Surviv. 2022 Jun;16(3):604-613 PMID: 33977342 PMCID: PMC11322957 SCOPUS ID: 2-s2.0-85105805769 05/13/2021
-
(Bikomeye JC, Beyer AM, Kwarteng JL, Beyer KMM.) Int J Environ Res Public Health. 2022 Feb 19;19(4) PMID: 35206610 PMCID: PMC8872601 SCOPUS ID: 2-s2.0-85124908145 02/26/2022
-
(Bikomeye JC, Balza JS, Kwarteng JL, Beyer AM, Beyer KMM.) PLoS One. 2022;17(11):e0276517 PMID: 36417344 PMCID: PMC9683573 SCOPUS ID: 2-s2.0-85142876878 11/24/2022
-
(Beyer KMM, Zhou Y, Laud PW, McGinley EL, Yen TWF, Jankowski C, Rademacher N, Namin S, Kwarteng J, Beltrán Ponce S, Nattinger AB.) J Clin Oncol. 2021 Sep 01;39(25):2749-2757 PMID: 34129388 PMCID: PMC8407650 SCOPUS ID: 2-s2.0-85115440319 06/16/2021
-
(Kwarteng JL, Beyer KMM, Banerjee A, Stolley MR.) Cancer Causes Control. 2020 Aug;31(8):737-747 PMID: 32415529 PMCID: PMC11196002 SCOPUS ID: 2-s2.0-85085011567 05/18/2020
-
(Kwarteng JL, Schulz AJ, Mentz GB, Israel BA, Perkins DW.) J Urban Health. 2017 Dec;94(6):791-802 PMID: 28895036 PMCID: PMC5722729 SCOPUS ID: 2-s2.0-85029107977 09/13/2017
-
(Kamaraju S, Mohan M, Wright T, Charlson J, Wiger W, Kwarteng J, Rezazadeh A, Hammons L and Power S.) J Radiol Oncol. Kamaraju S, Mohan M, Wright T, Charlson J, Wiger W, et al, Hammons L1 and Power S3. Addressing the disparities and the factors related to prolonged inpatient length of stay for solid tumor oncology patients during the COVID-19 pandemic: A narrative review. J Radiol Oncol. 2021; 5: 046-053. 09/17/2021